Go Pro
NYSE:CHE

Chemed (CHE) Stock Price, News & Analysis

Chemed logo
$510.28 +7.27 (+1.44%)
Closing price 07/24/2026 03:59 PM Eastern
Extended Trading
$510.88 +0.60 (+0.12%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Chemed Stock (NYSE:CHE)

Advanced

Key Stats

Today's Range
$501.74
$511.77
50-Day Range
$417.62
$513.83
52-Week Range
$365.20
$517.74
Volume
113,906 shs
Average Volume
156,789 shs
Market Capitalization
$6.77 billion
P/E Ratio
27.81
Dividend Yield
0.47%
Price Target
$480.25
Consensus Rating
Hold

Company Overview

Chemed Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
68th Percentile Overall Score

CHE MarketRank™: 

Chemed scored higher than 68% of companies evaluated by MarketBeat, and ranked 341st out of 836 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemed has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on no strong buy ratings, 1 buy rating, 5 hold ratings, and no sell ratings.

  • Downside Risk

    Chemed has a consensus price target of $480.25, representing about 5.9% downside from its current price of $510.28.

  • Amount of Analyst Coverage

    Chemed has only been the subject of 4 research reports in the past 90 days.

  • Read more about Chemed's stock forecast and price target.
  • Earnings Growth

    Earnings for Chemed are expected to grow by 13.67% in the coming year, from $22.67 to $25.77 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemed is 27.81, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.81.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemed is 27.81, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.14.

  • Price to Earnings Growth Ratio

    Chemed has a PEG Ratio of 1.88. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Chemed has a P/B Ratio of 7.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chemed's valuation and earnings.
  • Percentage of Shares Shorted

    4.41% of the float of Chemed has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemed has a short interest ratio ("days to cover") of 3.63, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemed has recently increased by 0.31%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Chemed has a dividend yield of 0.47%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chemed has been increasing its dividend for 16 years.

  • Dividend Coverage

    The dividend payout ratio of Chemed is 13.08%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Chemed will have a dividend payout ratio of 9.31% next year. This indicates that Chemed will be able to sustain or increase its dividend.

  • Read more about Chemed's dividend.
  • News Sentiment

    Chemed has a news sentiment score of 1.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 10 news articles for Chemed this week, compared to 4 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added Chemed to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,444,814.00 in company stock.

  • Percentage Held by Insiders

    3.33% of the stock of Chemed is held by insiders.

  • Percentage Held by Institutions

    95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemed's insider trading history.
Receive CHE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CHE Stock News Headlines

Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.tc pixel
See More Headlines

CHE Stock Analysis - Frequently Asked Questions

Chemed's stock was trading at $427.86 on January 1st, 2026. Since then, CHE shares have increased by 19.3% and is now trading at $510.2780.

Chemed Corporation (NYSE:CHE) released its quarterly earnings data on Thursday, April, 23rd. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.30 by $0.35. The firm's quarterly revenue was up 1.6% on a year-over-year basis.
Read the conference call transcript
.

Top institutional investors of Chemed include Legacy Wealth Asset Management LLC (0.02%), Trust Point Inc. (0.02%), Hennion & Walsh Asset Management Inc. (0.01%) and First Heartland Consultants Inc. (0.01%). Insiders that own company stock include Kevin J Mcnamara, Spencer S Lee, David Patrick Williams, Andrea R Lindell, George J Walsh III, Patrick P Grace, Michael D Witzeman, Brian C Judkins and Nicholas Michael Westfall.
View institutional ownership trends
.

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemed investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
4/23/2026
Record date for 6/16 Dividend
5/28/2026
Ex-Dividend for 6/16 Dividend
5/28/2026
Dividend Payable
6/16/2026
Today
7/26/2026
Next Earnings (Estimated)
7/28/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Health Care Services
Current Symbol
NYSE:CHE
CIK
19584
Employees
15,811
Year Founded
1970

Price Target and Rating

High Price Target
$510.00
Low Price Target
$436.00
Potential Upside/Downside
-5.9%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
$18.35
Trailing P/E Ratio
27.81
Forward P/E Ratio
22.51
P/E Growth
1.88
Net Income
$265.24 million
Net Margins
10.23%
Pretax Margin
13.73%
Return on Equity
27.18%
Return on Assets
17.38%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
0.85
Quick Ratio
0.83

Sales & Book Value

Annual Sales
$2.53 billion
Price / Sales
2.68
Cash Flow
$24.63 per share
Price / Cash Flow
20.72
Book Value
$69.15 per share
Price / Book
7.38

Miscellaneous

Outstanding Shares
13,270,000
Free Float
12,832,000
Market Cap
$6.77 billion
Optionable
Optionable
Beta
0.52

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NYSE:CHE) was last updated on 7/26/2026 by MarketBeat.com Staff.
From Our Partners